Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

HPV16 E7 (86-93) acetate

🥰Excellent
Catalog No. TP1554L
Alias HPV16 E7 (86-93) acetate(160212-93-1 Free base)

HPV16 E7 (86-93) acetate is a derived peptide of human leukocyte antigen A2.1 restricted HPV16 E7 with immunogenic property in cervical carcinomas.

HPV16 E7 (86-93) acetate

HPV16 E7 (86-93) acetate

🥰Excellent
Purity: 96.91%
Catalog No. TP1554LAlias HPV16 E7 (86-93) acetate(160212-93-1 Free base)
HPV16 E7 (86-93) acetate is a derived peptide of human leukocyte antigen A2.1 restricted HPV16 E7 with immunogenic property in cervical carcinomas.
Pack SizePriceAvailabilityQuantity
1 mg$77In Stock
5 mg$159In Stock
10 mg$226In Stock
25 mg$380In Stock
50 mg$530In Stock
100 mg$738In Stock
200 mg$996In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "HPV16 E7 (86-93) acetate"

Select Batch
Purity:96.91%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
HPV16 E7 (86-93) acetate is a derived peptide of human leukocyte antigen A2.1 restricted HPV16 E7 with immunogenic property in cervical carcinomas.
In vitro
HPV16 E7 peptide-loaded autologous dendritic cells stimulate a specific cytotoxic CD8+ T-cell response[1]. HPV16 E7 (86-93) acetate specific T cells expand upon in vitro stimulation with cognate peptide-pulsed dendritic cells. HPV16 E7 (86-93) acetate specific T cells are reactive against peptide-pulsed targets. HPV16 E7 (86-93) acetate specific E711-20 T cells are reactive against HPV16 E7 expressing CaSki cell line. Precursor T cells specific for HPV16 E7 (86-93) acetate differentiates into HPV specific effector cells in vitro[2].
In vivo
HPV16 E7 (86-93) acetate in IVS culture has specific T cell expansion without recognizing naturally HPV16 E7 expressing cell line CaSki. HPV16 E7 (86-93) acetate has similar observations in transgenic mice. HPV16 E7 (86-93) acetate induces cytotoxic T lymphocyte responses when loaded on the antigen presenting HLA class I molecules[2].
AliasHPV16 E7 (86-93) acetate(160212-93-1 Free base)
Chemical Properties
Molecular Weight875.08
FormulaC39H70N8O12S
SmilesC[C@@H](O)[C@H](N)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@@H](CS)C(N1CCC[C@H]1C(N[C@@H]([C@@H](C)CC)C(O)=O)=O)=O)=O)C(C)C)=O)[C@@H](C)CC)=O)=O)CC(C)C)=O.CC(O)=O
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy HPV16 E7 (86-93) acetate | purchase HPV16 E7 (86-93) acetate | HPV16 E7 (86-93) acetate cost | order HPV16 E7 (86-93) acetate | HPV16 E7 (86-93) acetate chemical structure | HPV16 E7 (86-93) acetate in vivo | HPV16 E7 (86-93) acetate in vitro | HPV16 E7 (86-93) acetate formula | HPV16 E7 (86-93) acetate molecular weight